Dr. Barry White
Clinical Associate Professor, Haematology
Clinical Associate Professor, Molecular Medicine Ireland
Publications and Further Research Outputs
Peer-Reviewed Publications
Byrne M, Reynolds JV, O'Donnell JS, Keogan M, White B, Byrne M, Murphy S, Maher SG, Pidgeon GP, Long-term activation of the pro-coagulant response after neoadjuvant chemoradiation and major cancer surgery., British Journal of Cancer, 102, (1), 2010, p73-9
McGrath, LB, Onnis, V, Campiani, G, Williams, DC, Zisterer, DM and McGee, MM, Caspase-activated DNase (CAD)-independent oligonucleosomal DNA fragmentation in chronic myeloid leukaemia cells; a requirement for serine protease and Mn(2+)-dependent acidic endonuclease activity., Apoptosis, 11, (9), 2006, p1473 - 1487
J. Balding, C. M. Healy, W. J. Livingstone, B. White, L. Mynett-Johnson, M. Cafferkey and O. P. Smith, Genomic polymorphic profiles in an Irish population with meningococcaemia: is it possible to predict severity and outcome of disease?, Genes and immunity, 4, (8), 2003, p533-40
L. A. Mynett-Johnson, C. Keenan, I. L. Black, W. J. Livingstone, M. Lawler, H. M. Roche, B. White, M. J. Gibney, P. McKeon and O. P. Smith, Thermolabile methylenetetrahydrofolate reductase (C677T): frequency in the Irish population, Irish journal of medical science, 171, (1), 2002, p37-9
Y. L. Woo, B. White, R. Corbally, M. Byrne, N. O'Connell, E. O'Shea, B. L. Sheppard, J. Bonnar and O. P. Smith, von Willebrand's disease: an important cause of dysfunctional uterine bleeding, Blood coagulation & fibrinolysis, 13, (2), 2002, p89-93
C. Keenan, W. J. Livingstone, B. White, L. Mynett-Johnson, S. Cusack, M. Lawler and O. P. Smith, Prevalence of the prothrombin G20210A mutation in the Irish populations: use of a novel polymerase chain reaction approach, Blood coagulation & fibrinolysis, 11, (7), 2000, p669-72
Y. S. Ang, N. Mahmud, B. White, M. Byrne, A. Kelly, M. Lawler, G. S. McDonald, O. P. Smith and P. W. Keeling, Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease, Alimentary pharmacology & therapeutics, 14, (8), 2000, p1015-22
W. J. Livingstone, C. Keenan, B. White, L. Mynett-Johnson, M. Lawler, P. Mayne and O. P. Smith, Prevalence of the factor VR506Q mutation in two Irish control populations: use of a novel nested polymerase chain reaction approach, British journal of haematology, 111, (2), 2000, p559-61
B. White, M. Schmidt, C. Murphy, W. Livingstone, D. O'Toole, M. Lawler, L. O'Neill, D. Kelleher, H. P. Schwarz and O. P. Smith, Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappaB (NF-kappaB) and tumour necrosis factor alpha (TNF-alpha) production in the THP-1 monocytic cell line, British journal of haematology, 110, (1), 2000, p130-4
B. White, W. Livingstone, C. Murphy, A. Hodgson, M. Rafferty and O. P. Smith, An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia, Blood, 96, (12), 2000, p3719-24
M. Schmidt-Supprian, C. Murphy, B. While, M. Lawler, A. Kapurniotu, W. Voelter, O. Smith and J. Bernhagen, Activated protein C inhibits tumor necrosis factor and macrophage migration inhibitory factor production in monocytes, European cytokine network, 11, (3), 2000, p407-13
B. White, M. Cotter, M. Byrne, E. O'Shea and O. P. Smith, High responding factor VIII inhibitors in mild haemophilia - is there a link with recent changes in clinical practice?, Haemophilia, 6, (2), 2000, p113-5
B. White, H. O'Connor and O. P. Smith, Successful use of recombinant VIIa (Novoseven) and endometrial ablation in a patient with intractable menorrhagia secondary to FVII deficiency, Blood coagulation & fibrinolysis, 11, (2), 2000, p155-7
O. P. Smith and B. White, Infectious purpura fulminans: caution needed in the use of protein c, British journal of haematology, 106, (1), 1999, p253-4
O. P. Smith and B. White, Infectious purpura fulminans: diagnosis and treatment, British journal of haematology, 104, (2), 1999, p202-7
B. White, M. Martin, S. Kelleher, P. Browne, S. R. McCann and O. P. Smith, Successful use of recombinant FVIIa (Novoseven) in the management of pulmonary haemorrhage secondary to Aspergillus infection in a patient with leukaemia and acquired FVII deficiency, British journal of haematology, 106, (1), 1999, p254-5
C. Duggan, M. Schmidt, M. Lawler, B. White, S. Cusack, S. McCann and O. Smith, The prothrombin gene variant G20210A but not factor V leiden may be associated with veno-occlusive disease following BMT, Bone marrow transplantation, 24, (6), 1999, p693-4
B. J. Hennessy, B. White, M. Byrne and O. P. Smith, Acquired von Willebrand's disease, Irish journal of medical science, 167, (2), 1998, p81-5
J. Guerin, O. Smith, B. White, G. Sweetman, C. Feighery and J. Jackson, Antibodies to prothrombin in antiphospholipid syndrome and inflammatory disorders, British journal of haematology, 102, (4), 1998, p896-902
B. White, K. W. Leong, G. M. Crotty and S. R. McCann, Hereditary spherocytosis: implications in bone marrow transplantation, Bone marrow transplantation, 21, (2), 1998, p215
K. W. Leong, B. Crowley, B. White, G. M. Crotty, D. S. O'Briain, C. Keane and S. R. McCann, Cutaneous mucormycosis due to Absidia corymbifera occurring after bone marrow transplantation, Bone marrow transplantation, 19, (5), 1997, p513-5
O. P. Smith, B. White, D. Vaughan, M. Rafferty, L. Claffey, B. Lyons and W. Casey, Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans, Lancet, 350, (9091), 1997, p1590-3
Recognition
Representations
Copy, Inflammatory Lung Disease, Proposed workshop on inflammatory diseases of the lung.Includes clinicians presenting on their specific disease type to fundamental scientists.Objectives :To build links between fundamental and clinican scientistsTo look for opportunities for trans-institutional collaborationTo connect senior post-docs (emerging PI's) with clinician counterpart